Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-12-002753
Filing Date
2012-09-27
Accepted
2012-09-27 14:23:17
Documents
1
Period of Report
2012-09-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1212075.html 3  
1 OWNERSHIP DOCUMENT zk1212075.xml 3 1494
  Complete submission text file 0001178913-12-002753.txt   3015
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 220 EAST FIRST STREET BETHLEHEM PA 18015
Business Address
OSTROV GERALD M (Reporting) CIK: 0001534739 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50298 | Film No.: 121112764